Literature DB >> 27343352

Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications.

Yessine Amri1, Choumous Kallel2, Mariem Becheur3, Rym Dabboubi4, Moez Elloumi5, Hatem Belaaj5, Sami Kammoun6, Taieb Messaoud4, Philippe de Moerloose7, Nour El Houda Toumi8.   

Abstract

BACKGROUND: Congenital disorders of fibrinogen are rare diseases resulting in the complete absence (afibrinogenemia), reduced concentration (hypofibrinogenemia) or altered function of circulating fibrinogen (dysfibrinogenemia). A combination of two different fibrinogen abnormalities with a significant functional and secretion defect (hypodysfibrinogenemia) reported in Tunisian family members, was investigated in this study.
METHODS: The coagulation-related tests, kinetics of fibrin polymerization and lysis and fibrinogen analysis using gel electrophoresis were performed in the family members to characterize fibrinogen abnormalities. All exons including exon-intron boundaries of fibrinogen genes were screened by direct sequencing.
RESULTS: Mutational screening of the fibrinogen genes disclosed novel missense mutations, BβCys197Arg, in exon 4 of the fibrinogen Bβ-chain gene. After the loose of its partner in Bβ-chain, the γCys135 was probably disulfide-bridged to its corresponding Cys residue of another abnormal fibrinogen molecule, forming dimmer with an abnormal electrophoretic profile. Homozygous form carried by the proband found to be directly involved in the bleeding phenotype by affecting fibrin polymerization. In contrast, affected family members bearing the heterozygous mutation showed an impaired fibrin polymerization and fibrinolysis leading to thrombosis.
CONCLUSION: These results suggest that this mutation could alter the extremely conserved conformations of fibrinogen D domain and D-D lateral regions on fibrin assembly.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bleeding; Fibrinolysis; Hypodysfibrinogenemia; Missense mutation; Polymerization; Thrombosis

Mesh:

Substances:

Year:  2016        PMID: 27343352     DOI: 10.1016/j.cca.2016.06.024

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  2 in total

1.  Dysfibrinogenemia and multiple sclerosis: spuriously associated or causally linked?

Authors:  V K Kimiskidis; E Papadakis; V Papaliagkas; S Papagiannopoulos; D K Galanakis
Journal:  Hippokratia       Date:  2017 Jan-Mar       Impact factor: 0.471

2.  Pediatric patient with fibrinogen Villeurbanne II presenting with an unprovoked portal vein thrombosis.

Authors:  Brenton J Francisco; Bal Krishan Sharma; Hannah M Russell; Leah Rosenfeldt; A Phillip Owens; Matthew J Flick; Eric S Mullins; Joseph Palumbo
Journal:  Blood Adv       Date:  2022-07-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.